BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8960826)

  • 1. Protein C activation in NIDDM patients.
    Gabazza EC; Takeya H; Deguchi H; Sumida Y; Taguchi O; Murata K; Nakatani K; Yano Y; Mohri M; Sata M; Shima T; Nishioka J; Suzuki K
    Diabetologia; 1996 Dec; 39(12):1455-61. PubMed ID: 8960826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.
    Mormile A; Veglio M; Gruden G; Girotto M; Rossetto P; D'Este P; Cavallo-Perin P
    Acta Diabetol; 1996 Sep; 33(3):241-5. PubMed ID: 8904933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus.
    Sumida Y; Wada H; Fujii M; Mori Y; Nakasaki T; Shimura M; Hiyoyama K; Yano Y; Deguchi K; Shiku H; Adachi Y
    Blood Coagul Fibrinolysis; 1997 Jul; 8(5):303-7. PubMed ID: 9282795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prothrombin fragment 1 + 2 and D-dimer in first-degree relatives of type 2 diabetic patients. Prethrombotic state in relatives of type 2 diabetic patients.
    Fernández-Castañer M; Camps I; Fernández-Real JM; Domenech P; Martínez-Brotons F
    Acta Diabetol; 1996 Jul; 33(2):118-21. PubMed ID: 8870813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
    Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
    Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes.
    Aso Y; Fujiwara Y; Tayama K; Takebayashi K; Inukai T; Takemura Y
    Clin Chim Acta; 2000 Nov; 301(1-2):135-45. PubMed ID: 11020468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients.
    Ceriello A; Bortolotti N; Pirisi M; Crescentini A; Tonutti L; Motz E; Russo A; Giacomello R; Stel G; Taboga C
    Diabetes Care; 1997 Oct; 20(10):1589-93. PubMed ID: 9314640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects.
    De CR; Rocca B; Marchioli R; Landolfi R
    Thromb Haemost; 2002 Jan; 87(1):58-67. PubMed ID: 11848457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical training decreases plasma thrombomodulin in type I and type II diabetic patients.
    Rigla M; Fontcuberta J; Mateo J; Caixàs A; Pou JM; de Leiva A; Pérez A
    Diabetologia; 2001 Jun; 44(6):693-9. PubMed ID: 11440361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of blood-coagulation vitamin K-dependent proteins in the activation of human protein C. Involvement of the 4-carboxyglutamic acid domain in two distinct interactions with the thrombin-thrombomodulin complex and with phospholipids.
    Freyssinet JM; Beretz A; Klein-Soyer C; Gauchy J; Schuhler S; Cazenave JP
    Biochem J; 1988 Dec; 256(2):501-7. PubMed ID: 2851994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin-resistant prothrombin Yukuhashi mutation also causes thrombomodulin resistance in fibrinogen clotting but not in protein C activation.
    Takagi Y; Kato I; Ando Y; Nakamura Y; Murata M; Takagi A; Murate T; Kojima T
    Thromb Res; 2014 Oct; 134(4):914-7. PubMed ID: 25149909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease.
    Welters I; Menges T; Ballesteros M; Knothe C; Ruwoldt R; Görlach G; Hempelmann G
    Thromb Res; 1998 Oct; 92(1):1-9. PubMed ID: 9783668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin.
    Katayama S; Nunomiya S; Koyama K; Wada M; Koinuma T; Goto Y; Tonai K; Shima J
    Crit Care; 2017 Aug; 21(1):229. PubMed ID: 28841902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased P-selectin expression on platelets and decreased plasma thrombomodulin in Fontan patients.
    Kajimoto H; Nakazawa M; Murasaki K; Hagiwara N; Nakanishi T
    Circ J; 2009 Sep; 73(9):1705-10. PubMed ID: 19638712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of circulating dehydroepiandrosterone with activated protein C generation and carotid intima-media thickness in male patients with type 2 diabetes.
    Suzuki T; Yano Y; Sakamoto M; Uemura M; Yasuma T; Onishi Y; Sasaki R; Matsumoto K; Hayashi T; Maruyama-Furuta N; Akatsuka H; Gabazza EC; Sumida Y; Takei Y
    Diabet Med; 2012 Jul; 29(7):e41-6. PubMed ID: 22248365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
    Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
    Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bariatric surgery in morbidly obese individuals affects plasma levels of protein C and thrombomodulin.
    Rega-Kaun G; Kaun C; Ebenbauer B; Jaegersberger G; Prager M; Wojta J; Hohensinner PJ
    J Thromb Thrombolysis; 2019 Jan; 47(1):51-56. PubMed ID: 30259314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protein C system in patients with idiopathic pulmonary fibrosis--preliminary report].
    Kiziewicz A; Zekanowska E; Cieśliński K; Góralczyk K
    Pneumonol Alergol Pol; 2008; 76(4):225-8. PubMed ID: 18785126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function.
    Adams MJ; Irish AB; Watts GF; Oostryck R; Dogra GK
    Thromb Res; 2008; 123(2):374-80. PubMed ID: 18486198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.